![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MCTS1 |
Gene summary for MCTS1 |
![]() |
Gene information | Species | Human | Gene symbol | MCTS1 | Gene ID | 28985 |
Gene name | MCTS1 re-initiation and release factor | |
Gene Alias | MCT-1 | |
Cytomap | Xq24 | |
Gene Type | protein-coding | GO ID | GO:0001731 | UniProtAcc | Q9ULC4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
28985 | MCTS1 | LZE4T | Human | Esophagus | ESCC | 2.76e-14 | 3.29e-01 | 0.0811 |
28985 | MCTS1 | LZE7T | Human | Esophagus | ESCC | 1.15e-11 | 9.32e-01 | 0.0667 |
28985 | MCTS1 | LZE8T | Human | Esophagus | ESCC | 2.33e-03 | 2.98e-01 | 0.067 |
28985 | MCTS1 | LZE20T | Human | Esophagus | ESCC | 3.47e-03 | 3.43e-01 | 0.0662 |
28985 | MCTS1 | LZE22D1 | Human | Esophagus | HGIN | 8.19e-03 | 7.41e-02 | 0.0595 |
28985 | MCTS1 | LZE24T | Human | Esophagus | ESCC | 5.85e-31 | 1.03e+00 | 0.0596 |
28985 | MCTS1 | LZE21T | Human | Esophagus | ESCC | 9.48e-06 | 5.74e-01 | 0.0655 |
28985 | MCTS1 | LZE6T | Human | Esophagus | ESCC | 9.21e-10 | 6.29e-01 | 0.0845 |
28985 | MCTS1 | P1T-E | Human | Esophagus | ESCC | 1.20e-10 | 6.33e-01 | 0.0875 |
28985 | MCTS1 | P2T-E | Human | Esophagus | ESCC | 9.61e-34 | 6.86e-01 | 0.1177 |
28985 | MCTS1 | P4T-E | Human | Esophagus | ESCC | 3.08e-44 | 1.10e+00 | 0.1323 |
28985 | MCTS1 | P5T-E | Human | Esophagus | ESCC | 1.96e-46 | 1.00e+00 | 0.1327 |
28985 | MCTS1 | P8T-E | Human | Esophagus | ESCC | 1.85e-23 | 5.85e-01 | 0.0889 |
28985 | MCTS1 | P9T-E | Human | Esophagus | ESCC | 1.46e-42 | 1.08e+00 | 0.1131 |
28985 | MCTS1 | P10T-E | Human | Esophagus | ESCC | 1.62e-54 | 1.11e+00 | 0.116 |
28985 | MCTS1 | P11T-E | Human | Esophagus | ESCC | 7.38e-15 | 8.66e-01 | 0.1426 |
28985 | MCTS1 | P12T-E | Human | Esophagus | ESCC | 3.32e-23 | 4.72e-01 | 0.1122 |
28985 | MCTS1 | P15T-E | Human | Esophagus | ESCC | 2.21e-28 | 6.31e-01 | 0.1149 |
28985 | MCTS1 | P16T-E | Human | Esophagus | ESCC | 1.42e-19 | 3.91e-01 | 0.1153 |
28985 | MCTS1 | P17T-E | Human | Esophagus | ESCC | 1.22e-13 | 7.26e-01 | 0.1278 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:190300814 | Prostate | Tumor | organelle disassembly | 41/3246 | 114/18723 | 1.41e-06 | 2.53e-05 | 41 |
GO:000173113 | Prostate | Tumor | formation of translation preinitiation complex | 7/3246 | 11/18723 | 8.04e-04 | 5.44e-03 | 7 |
GO:002261329 | Skin | cSCC | ribonucleoprotein complex biogenesis | 302/4864 | 463/18723 | 5.13e-72 | 3.22e-68 | 302 |
GO:000218129 | Skin | cSCC | cytoplasmic translation | 127/4864 | 148/18723 | 4.83e-53 | 7.57e-50 | 127 |
GO:007182629 | Skin | cSCC | ribonucleoprotein complex subunit organization | 140/4864 | 227/18723 | 5.54e-30 | 3.16e-27 | 140 |
GO:002261829 | Skin | cSCC | ribonucleoprotein complex assembly | 136/4864 | 220/18723 | 2.60e-29 | 1.25e-26 | 136 |
GO:001603229 | Skin | cSCC | viral process | 211/4864 | 415/18723 | 7.04e-28 | 2.76e-25 | 211 |
GO:0006413111 | Skin | cSCC | translational initiation | 84/4864 | 118/18723 | 9.12e-25 | 2.29e-22 | 84 |
GO:0022411112 | Skin | cSCC | cellular component disassembly | 201/4864 | 443/18723 | 4.09e-19 | 5.69e-17 | 201 |
GO:0002183111 | Skin | cSCC | cytoplasmic translational initiation | 30/4864 | 34/18723 | 3.77e-14 | 2.49e-12 | 30 |
GO:190300817 | Skin | cSCC | organelle disassembly | 65/4864 | 114/18723 | 2.03e-12 | 1.12e-10 | 65 |
GO:001908019 | Skin | cSCC | viral gene expression | 50/4864 | 94/18723 | 1.68e-08 | 5.04e-07 | 50 |
GO:001908118 | Skin | cSCC | viral translation | 15/4864 | 16/18723 | 1.97e-08 | 5.79e-07 | 15 |
GO:007552215 | Skin | cSCC | IRES-dependent viral translational initiation | 11/4864 | 11/18723 | 3.61e-07 | 7.18e-06 | 11 |
GO:000173115 | Skin | cSCC | formation of translation preinitiation complex | 10/4864 | 11/18723 | 1.17e-05 | 1.50e-04 | 10 |
GO:0022613113 | Thyroid | PTC | ribonucleoprotein complex biogenesis | 292/5968 | 463/18723 | 3.24e-44 | 2.05e-40 | 292 |
GO:0002181113 | Thyroid | PTC | cytoplasmic translation | 121/5968 | 148/18723 | 4.32e-36 | 4.54e-33 | 121 |
GO:0016032113 | Thyroid | PTC | viral process | 236/5968 | 415/18723 | 2.48e-26 | 8.24e-24 | 236 |
GO:0022411113 | Thyroid | PTC | cellular component disassembly | 232/5968 | 443/18723 | 1.36e-19 | 1.75e-17 | 232 |
GO:0006413112 | Thyroid | PTC | translational initiation | 84/5968 | 118/18723 | 1.89e-18 | 2.09e-16 | 84 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MCTS1 | SNV | Missense_Mutation | rs750185102 | c.5G>A | p.Gly2Asp | p.G2D | Q9ULC4 | protein_coding | deleterious_low_confidence(0) | benign(0.07) | TCGA-A1-A0SJ-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
MCTS1 | SNV | Missense_Mutation | c.81G>T | p.Lys27Asn | p.K27N | Q9ULC4 | protein_coding | deleterious(0) | probably_damaging(0.944) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MCTS1 | SNV | Missense_Mutation | c.433N>C | p.Cys145Arg | p.C145R | Q9ULC4 | protein_coding | deleterious(0) | benign(0.239) | TCGA-A6-2684-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
MCTS1 | SNV | Missense_Mutation | c.491N>A | p.Gly164Asp | p.G164D | Q9ULC4 | protein_coding | deleterious(0.02) | benign(0.226) | TCGA-AA-3672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
MCTS1 | SNV | Missense_Mutation | c.27A>C | p.Lys9Asn | p.K9N | Q9ULC4 | protein_coding | deleterious(0.03) | benign(0.267) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
MCTS1 | SNV | Missense_Mutation | novel | c.96N>T | p.Glu32Asp | p.E32D | Q9ULC4 | protein_coding | tolerated(0.28) | benign(0) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
MCTS1 | SNV | Missense_Mutation | c.224G>A | p.Arg75Lys | p.R75K | Q9ULC4 | protein_coding | tolerated(0.44) | benign(0.203) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MCTS1 | SNV | Missense_Mutation | novel | c.141N>T | p.Lys47Asn | p.K47N | Q9ULC4 | protein_coding | deleterious(0) | possibly_damaging(0.847) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MCTS1 | SNV | Missense_Mutation | c.314T>C | p.Phe105Ser | p.F105S | Q9ULC4 | protein_coding | deleterious(0.03) | possibly_damaging(0.455) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MCTS1 | SNV | Missense_Mutation | c.398N>C | p.Val133Ala | p.V133A | Q9ULC4 | protein_coding | deleterious(0.01) | probably_damaging(0.956) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |